Sara Frank Discusses How to “Ramp Up Resources for Clinical and R&D Oversight to Achieve Compliance Excellence Throughout the Product Lifecycle”

Sara Frank will moderate the panel “Ramp Up Resources for Clinical and R&D Oversight to Achieve Compliance Excellence Throughout the Product Lifecycle” at CBI’s Compliance Congress for Specialty Products Conference on Friday, September 13. The panel will include representatives from Boston Biomedical, Boehringer Ingelheim and Sanofi Genzyme.

To learn more, click here.